4.7 Article

Superficial Slow Rhythms Integrate Cortical Processing in Humans

Journal

SCIENTIFIC REPORTS
Volume 8, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-20662-0

Keywords

-

Funding

  1. National Institutes of Health [R01-MH-099645, R01-EB-009282, R01-NS-062092, K24-NS-088568]
  2. U.S. Office of Naval Research [N00014-13-1-0672]
  3. MGH Executive Council on Research
  4. Hungarian National Brain Research Program grant [KTIA_13_NAP-A-IV/1-4,6]
  5. EU [600925]
  6. Hungarian Government [KTIA-NAP 13-1-2013-0001, OTKA PD101754]
  7. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009282] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099645] Funding Source: NIH RePORTER
  9. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062092, K24NS088568] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The neocortex is composed of six anatomically and physiologically specialized layers. It has been proposed that integration of activity across cortical areas is mediated anatomically by associative connections terminating in superficial layers, and physiologically by slow cortical rhythms. However, the means through which neocortical anatomy and physiology interact to coordinate neural activity remains obscure. Using laminar microelectrode arrays in 19 human participants, we found that most EEG activity is below 10-Hz (delta/theta) and generated by superficial cortical layers during both wakefulness and sleep. Cortical surface grid, grid-laminar, and dual-laminar recordings demonstrate that these slow rhythms are synchronous within upper layers across broad cortical areas. The phase of this superficial slow activity is reset by infrequent stimuli and coupled to the amplitude of faster oscillations and neuronal firing across all layers. These findings support a primary role of superficial slow rhythms in generating the EEG and integrating cortical activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Real-world user experience with seizure detection wearable devices in the home environment

Levente Hadady, Peter Klivenyi, Daniel Fabo, Sandor Beniczky

Summary: This study evaluated the direct user experience with wearable seizure detection devices in the home environment. The results showed that users were overall satisfied with the device, found it easy to use, and believed that it improved their quality of life. In the home environment, most users experienced seizure detection sensitivity similar to previous validation studies, with a relatively low false alarm rate. The use of the device resulted in a decrease in seizure-related injuries for some patients and improved the accuracy of seizure diaries for the majority. Nonvalidated devices had lower retention rate, satisfaction, sensitivity, and improvement in quality of life compared to validated devices.

EPILEPSIA (2022)

Article Clinical Neurology

Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation study

Levente Hadady, Peter Klivenyi, Emilio Perucca, Stefan Rampp, Daniel Fabo, Csaba Bereczki, Guido Rubboli, Ali A. Asadi-Pooya, Michael R. Sperling, Sandor Beniczky

Summary: The study validated that the use of the algorithm recommending ASMs based on individual characteristics is associated with better outcomes compared to using less desirable ASMs, including higher retention rates, higher seizure freedom rates, and fewer discontinuations due to adverse effects. The freely available decision support system proved to be beneficial for healthcare professionals in prescribing medication for individuals with epilepsy.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Perisomatic Inhibition and Its Relation to Epilepsy and to Synchrony Generation in the Human Neocortex

Estilla Zsofia Toth, Felicia Gyoengyver Szabo, Agnes Kandracs, Noemi Orsolya Molnar, Gabor Nagy, Attila G. Bago, Lorand Eross, Daniel Fabo, Boglarka Hajnal, Bence Racz, Lucia Wittner, Istvan Ulbert, Kinga Toth

Summary: Inhibitory neurons play a crucial role in synchronous events, especially in epileptic patients; in focal cortical epilepsy, parvalbumin cells have a stronger influence.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Clinical Neurology

Epilepsy Mortality The Unseen and Unknown

Orrin Devinsky

NEUROLOGY (2022)

Article Multidisciplinary Sciences

Imagined speech can be decoded from low- and cross-frequency intracranial EEG features

Timothee Proix, Jaime Delgado Saa, Andy Christen, Stephanie Martin, Brian N. Pasley, Robert T. Knight, Xing Tian, David Poeppel, Werner K. Doyle, Orrin Devinsky, Luc H. Arnal, Pierre Megevand, Anne-Lise Giraud

Summary: Researchers extracted consistent and specific neural features from patients performing speech production tasks and found that low-frequency power and cross-frequency dynamics play a key role in decoding imagined speech.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

A cortical network processes auditory error signals during human speech production to maintain fluency

Muge Ozker, Werner Doyle, Orrin Devinsky, Adeen Flinker

Summary: Hearing one's own voice is crucial for fluent speech production and can help detect and correct vocalization errors in real time. Research has found that both the auditory cortex and the dorsal precentral gyrus play important roles in processing auditory error signals during speech production.

PLOS BIOLOGY (2022)

Article Psychology, Biological

Multiscale temporal integration organizes hierarchical computation in human auditory cortex

Sam Norman-Haignere, Laura K. Long, Orrin Devinsky, Werner Doyle, Ifeoma Irobunda, Edward M. Merricks, Neil A. Feldstein, Guy M. McKhann, Catherine A. Schevon, Adeen Flinker, Nima Mesgarani

Summary: The human brain integrates information across multiple timescales to derive meaning from sound. Our study reveals that the auditory cortex hierarchically integrates across diverse timescales ranging from 50 to 400 ms, and different neural populations with short and long integration windows exhibit distinct functional properties.

NATURE HUMAN BEHAVIOUR (2022)

Article Clinical Neurology

Serotonin transporter in the temporal lobe, hippocampus and amygdala in SUDEP

Smriti Patodia, Alyma Somani, Joan Liu, Alice Cattaneo, Beatrice Paradiso, Maria Garcia, Muhammad Othman, Beate Diehl, Orrin Devinsky, James D. Mills, Jackie Foong, Maria Thom

Summary: Multiple lines of evidence suggest a link between deficient serotonin function and SUDEP, with chronic treatment using serotonin reuptake inhibitors shown to reduce the risk factors associated with SUDEP. Decreased medullary serotonergic neurons, which regulate respiration in response to hypercapnia, have been found in post-mortem SUDEP cases. Additionally, the high innervation of serotonergic neurons in the amygdala and hippocampus, regions involved in seizure-related respiratory dysregulation, further supports the potential involvement of altered serotonergic networks in SUDEP.

BRAIN PATHOLOGY (2022)

Article Clinical Neurology

Long- term efficacy and safety of cannabidiol in patients with treatment- resistant epilepsies: Four- year results from the expanded access program

Jerzy P. P. Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D. D. Park, Pilar Pichon Zentil, Anup D. D. Patel, Elizabeth A. A. Thiele, Robert T. T. Wechsler, Daniel Checketts, Farhad Sahebkar

Summary: The CBD expanded access program initiated in 2014 provided additional CBD treatment for patients with treatment-resistant epilepsies. The study showed that CBD treatment was effective in reducing seizure frequency and had an acceptable safety profile for long-term use in patients with treatment-resistant epilepsies.

EPILEPSIA (2023)

Article Clinical Neurology

Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program

Robert J. Flamini, Anne M. Comi, E. Martina Bebin, Michael G. Chez, Gary Clark, Orrin Devinsky, Shaun A. Hussain, Paul D. Lyons, Anup D. Patel, Jillian L. Rosengard, Farhad Sahebkar, Eric Segal, Laurie Seltzer, Jerzy P. Szaflarski, Arie Weinstock

Summary: The CBD Expanded Access Program provided CBD treatment to patients with treatment-resistant epilepsy and showed a significant reduction in seizure frequency. CBD was well tolerated and effective in treating both convulsive and nonconvulsive seizure types. Controlled trials are needed to further confirm these findings.

EPILEPSIA (2023)

Editorial Material Clinical Neurology

Failure to use new breakthrough treatments for epilepsy

Pavel Klein, Gregory L. Krauss, Bernhard J. Steinhoff, Orrin Devinsky, Michael R. Sperling

Summary: Despite the approval of numerous antiseizure medications (ASMs), a significant number of epilepsy patients still experience seizures. Two new ASMs, cenobamate and fenfluramine, have shown improved efficacy in reducing seizures with sustained results. However, these medications are underutilized, likely due to limited knowledge, access restrictions, and insufficient post-launch information about their efficacy and safety. Addressing these issues can improve seizure control and ultimately reduce morbidity and mortality in epilepsy patients.

EPILEPSIA (2023)

Article Clinical Neurology

Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial

Joseph Sullivan, Lieven Lagae, J. Helen Cross, Orrin Devinsky, Renzo G. Guerrini, Kelly Knupp, Linda Laux, Marina Nikanorova, Tilman Polster, Dinesh Talwar, Berten Ceulemans, Rima M. Nabbout, Gail S. Farfel, Bradley R. Galer, Arnold Gammaitoni, Michael Lock, Anupam E. Agarwal, Ingrid Scheffer, FAiRE DS Study Grp

Summary: This study examined the safety and effectiveness of fenfluramine in treating convulsive seizures in patients with Dravet syndrome. The results showed that patients treated with fenfluramine had lower seizure frequency and longer interval between seizures compared to the placebo group. Common side effects of fenfluramine were observed, but no evidence of severe cardiac or vascular issues was found.

EPILEPSIA (2023)

Review Clinical Neurology

Are brief febrile seizures benign? A systematic review and narrative synthesis

Laura Gould, Victoria Delavale, Caitlin Plovnick, Thomas Wisniewski, Orrin Devinsky

Summary: Febrile seizures are associated with an increased risk of epilepsy and rare cases of sudden unexplained death. Mortality rates varied in different studies, with some reporting no deaths and others identifying a significant percentage of deaths associated with febrile seizures. Minor hippocampal histopathological anomalies were common in sudden deaths with or without a history of febrile seizures. Most electroencephalography (EEG) studies were normal, and neuroimaging studies suggested increased right hippocampal volumes. Longer-term prospective studies are needed to fully understand the outcomes of simple or brief complex febrile seizures.

EPILEPSIA (2023)

Article Multidisciplinary Sciences

Closed-loop brain stimulation augments fear extinction in male rats

Rodrigo Ordonez Sierra, Lizeth Katherine Pedraza, Livia Barcsai, Andrea Pejin, Qun Li, Gabor Kozak, Yuichi Takeuchi, Anett J. Nagy, Magor L. Lorincz, Orrin Devinsky, Gyoergy Buzsaki, Antal Berenyi

Summary: Dysregulated fear reactions can be caused by maladaptive processing of trauma-related memories. By manipulating hippocampal SWRs and cortical oscillations, fear extinction can be enhanced in male rats. The modified fear memories become resistant to recall and do not spontaneously reemerge. This effect is mediated by D2 receptor signaling-induced synaptic remodeling in the basolateral amygdala. These findings demonstrate the potential of neuromodulation in augmenting extinction learning and provide a new avenue for anxiety disorder treatments.

NATURE COMMUNICATIONS (2023)

Article Clinical Neurology

Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-up

Heather E. Olson, Sam Amin, Nadia Bahi-Buisson, Orrin Devinsky, Eric D. Marsh, Elia Pestana-Knight, Rajsekar R. Rajaraman, Alex A. Aimetti, Eva Rybak, Fanhui Kong, Ian Miller, Joseph Hulihan, Scott Demarest

Summary: This study reports the 2-year safety and clinical outcomes of ganaxolone treatment in patients with CDD. The results show that ganaxolone significantly reduces major motor seizure frequency and maintains its efficacy and safety over the long term.

EPILEPSIA (2023)

No Data Available